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a b s t r a c t
Candida pneumonia is a rare infection of the lungs, with the majority of cases occurring secondary to
hematological dissemination of Candida organisms from a distant site, usually the gastrointestinal tract
or skin. We report a case of a 77-year-old male who is life-long smoker with a history of rheumatoid
arthritis and polymyalgia rheumatica, but did not take immunosuppressants for those conditions. Here,
we present an extremely rare case of isolated pulmonary parenchymal Candida infection in the form
pulmonary nodules without evidence of systemic disease which has only been described in a few pre-
vious reports.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Candida is a part of the normal oropharyngeal flora and upper
respiratory tract. Candida pneumonia, however, is a rare infection
of the lungs most commonly seen as part of a disseminated
Candida infection associated with predisposing clinical circum-
stances, such as long-term antibiotic use, hematologic malig-
nancy, or severe immunosuppressive states [1,2]. The majority of
Candida pneumonia cases are secondary to hematological
dissemination of Candida organisms from a distant site, usually
the gastrointestinal tract or skin [3]. Diagnosis of pulmonary
candidiasis is difficult because there is no specific clinical or
radiological presentation. Moreover, the presence of Candida in
sputum or other respiratory tract specimens often represents
contamination [4]. A definitive diagnosis of Candida pneumonia
relies on pathological findings of pulmonary parenchymal inva-
sion in histopathological samples [5,6]. There is no clear definition
or clinical predictive model to differentiate Candida pneumonia
from other forms of candidiasis. Furthermore, Candida pneumonia
has a high morbidity and is often fatal. Here, we present a rare case
of Candida infection in the form of pulmonary nodules in an
apparently healthy individual.
Case presentation
A 77-year-old white male presented with multiple pulmonary
nodules. He is a life-long smoker with a history of rheumatoid
arthritis and polymyalgia rheumatica, but did not take immuno-
suppressants for those conditions. The nodules were discovered via
chest computed tomography to investigate the recent onset of
dyspnea. His dyspnea was associated with coughing up copious
amounts of yellowish to dark sputum. There were no complaints of
fever, night sweats, weight loss, chest pains, or hemoptysis. He was
treated for pneumonia, but the suspicious pulmonary nodules
triggered further examination by positron emission tomography
(PET) to evaluate the risk of cancer. The PET scan revealed the
nodule was PET-avid indicating an increased risk of malignancy. An
initial biopsy of the most suspicious spiculated nodule (1.3 cm) was
negative. Given the increased risk of malignancy, a second biopsy
was obtained. During this time, the patient did not show significant
symptomatic improvement. The second biopsy showed Acute and
chronic granulomatous inflammation with Caseous necrosis.
The GMS stain reveals numerous yeast forms showing wide
variation in size and shapewith scatted budding and rare very early
hypheal type structures. Many stain lightlywithmucin but show no
halos. This is consistent with a Candida species possibly glabrata.
Management and outcome
The patient began fluconazole to treat his invasive Candida
pneumonia. Due to the absence of immunosuppression, in-
vestigations were initiated to rule out an acquired or mild inherited
immunodeficiency disorder. A skin candida delayed
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hypersensitivity test (Candin) was performed and revealed anergy
to Candida elements. The patient's Immunoglobulin G (IgG) levels
weremildly decreased to 693 (lower normal limit, 765), and hewas
initially lymphopenic without leukopenia (total lymphocyte count,
1400). Although his CD4 count was normal, his naïve CD4 count
was only 4%, and his total B cell count was reduced. This indicated
an acquired form of relative immunodeficiency prohibiting the
patient from mounting immune responses to newly encountered
pathogens and is probably the cause of his low IgG levels. After 6
months of fluconazole treatment, all nodules showed significant
regression, and his symptoms have greatly improved with the
exception of a chronic cough with production of clear sputum
which was attributed to his chronic obstructive pulmonary disor-
der. From initial evaluation to extended 18-month follow-up, the
patient did not exhibit any sign of disseminated candidiasis.
Discussion
Although the diagnosis of isolated Candida pneumonia is rare,
the presence of Candida on pathological samples should never be
ignored. Our case represents a singular occurrence of Candida
pneumonia with an uncommon manifestation. Unlike known pre-
sentations, including aspiration-related asbcesses, lobar infiltrate
pneumonia, or hematologic dissemination, our case involved an
isolated parenchymal infection in the form of pulmonary nodules
without evidence of systemic disease, which is extremely rare and
only described in a few previous reports [7]. Interesting, the low
level of immunodeficiency we identified in this case might have
been responsible for the increased risk of infection [8,9]. However,
this cannot be clearly confirmed given the lack of dissemination
and repeated infection. On the contrary, the absence of repeated or
chronic infection causes us to doubt whether his level of immu-
nodeficiency is clinically relevant. Alternatively, the lack of severe
immunodeficiency likely prevented dissemination and helped
contain an often fatal disease without apparent systemic
symptoms.
Another interesting aspect of this case was the need for two
biopsies to secure a diagnosis, which is often not possible. With a
case like ours, we wonder how an effective diagnosis could have
been made otherwise. Since Candida growth in the sputum is
almost always considered contamination, sputum cultures are not
especially useful. Even though fungal serology was negative in this
case, these tests are known to be insensitive in healthy individuals.
Likewise, predictive models which differentiate infection from
contamination are also very insensitive and non-specific. Thus,
there is currently a definite need to develop a clinical model that
enables reliably accurate identification and treatment of Candida
infections without the need for multiple biopsies.
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